Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1358223
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1358223
Antibiotic Resistance Market, By Disease Type, By Pathogen Type, By Drug Class, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 299 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Antibiotic Resistance Market size was valued at USD 8,005.7 million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.
Antibiotic resistance emerges when bacteria adapt to the usage of these medications. It develops in bacteria instead of people or animals. These bacteria can infect humans and animals, and their infections are more difficult to treat than infections caused by non-resistant bacteria. Antibiotic resistance is accelerated by antibiotic abuse and overuse, as well as inadequate infection prevention and control. At all levels of society, steps can be made to decrease the impact and spread of resistance. Antibiotic resistance is a global issue and requires cooperation between nations, industries, and organizations. Investing in the development of new antibiotics, as well as alternative therapies like bacteriophages and antimicrobial peptides. For example, Methicillin-Resistant Staphylococcus Aureus (MRSA's) emergence and spread show the quick rate at which germs can adapt to drugs, as well as the continual problem that healthcare personnel face in treating bacterial illnesses. It emphasizes the critical need for effective antibiotic usage, improved infection control procedures, and the discovery of novel antibiotics.
Antibiotic Resistance Market - Market Dynamics:
- Increasing the prevalence of bacterial infection to increase market growth
- The increasing prevalence of bacterial illnesses resistant to conventional antibiotics may increase demand for novel remedies, driving market growth. As antibiotic resistance spreads, the need for new antibiotics becomes more pressing. This could lead to increased investment in R&D by pharmaceutical corporations. Global comprehensive estimates of the burden of bacterial infections have been published. In 2019, 7.7 million deaths around the world were found to be linked to bacterial infections. That equals 1 in 8 of all global deaths. The integration of AI and machine learning in drug research provides a growth opportunity to accelerate the creation of novel antibiotics. However, Antibiotic resistance is not widely recognized by the general population and even by healthcare providers. This can lead to incorrect prescribing and abuse.
Antibiotic Resistance Market - Key Insights:
- As per the analysis shared by our research analyst, the global Antibiotic Resistance market is estimated to grow annually at a CAGR of around 6.1% over the forecast period (2023-2030)
- Based on Disease type segmentation, Urinary Tract Infections was predicted to show maximum market share in the year 2022
- Based on Pathogen Type segmentation, Acinetobacter Baumannii was the leading type in 2022
- Based on Drug class segmentation, Oxazolidinones were the leading type in 2022
- Based on End-User segmentation, Hospitals was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Antibiotic Resistance Market- Segmentation Analysis:
- The Global Antibiotic Resistance Market is segmented on the basis of Disease type, Pathogen Type, Drug class, End-User, and Region.
- The market is divided into four categories based on Disease type: Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, and Others. Urinary Tract Infections dominate the market growth. UTIs are one of the most common bacterial diseases that affect humans, particularly women. UTIs are often treated with antibiotics. However, with the increasing prevalence of antibiotic resistance, managing and treating UTIs is becoming more difficult.
- The market is divided into four categories based on Pathogen Type: Acinetobacter Baumannii, Pseudomonas Aeruginosa, Staphylococcus Aureus, Streptococcus pneumonia, and Others. Acinetobacter Baumannii dominates the market growth. A. baumannii has an inherent propensity to rapidly acquire resistance mechanisms, making it one of the most troublesome infections in hospital settings, particularly in intensive care units (ICUs).
- The market is divided into three categories based on Drug class: Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others. The Oxazolidinones sector dominates the market and is likely to maintain its dominance during the forecast period. Oxazolidinones are antibiotics that are used to treat bacterial infections, particularly those caused by Gram-positive pathogens. Linezolid is the most well-known oxazolidinone. They are especially significant since they have been shown to be effective against multi-drug resistance pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
- The market is divided into three categories based on End-User: Hospitals, Homecare, Specialty Clinics, and Others. The hospital sector dominates the market. Hospitals are essential to the development of antibiotic resistance. They are both a breeding ground for resistant bacteria and a main battleground for treating people sick with these superbugs. The implications for hospitals in the face of developing antibiotic resistance are complex, with considerable ramifications for the healthcare market.
Antibiotic Resistance Market - Geographical Insights:
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to the increasing prevalence of infectious diseases and rising healthcare expenditure. North America, especially the United States, has had outbreaks of many infectious diseases, some of which are antibiotic-resistant. MRSA (Methicillin-resistant Staphylococcus aureus), for example, has become a major concern in many U.S. hospitals and healthcare settings. The United States spends more on healthcare per capita than any other country in the world. According to the American Medical Association, a significant amount of the revenue is spent on research, drug development, and diagnostics. Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD 12,914 per capita. This growth rate is substantially lower than in 2020 (10.3% percent). Europe and Asia Pacific are projected to demand for Bispecific Resistance Market, due to the growing demand for effective antibiotic therapies.
Antibiotic Resistance Market- Competitive Landscape:
Antibiotic resistance has emerged as a major global concern. As bacteria evolve and become resistant to existing medicines, infections become more challenging to treat, leading to longer illnesses, more hospitalizations, and a rise in mortality. The manufacturers have been active in antibiotic research, however owing to economic pressures, some large pharmaceutical corporations have reduced or discontinued their antibiotic research projects. Pfizer, Merck, GlaxoSmithKline, and Roche represent some of the companies involved in the pharmaceutical industry. A comprehensive competitive study must consider pharmaceutical businesses, diagnostic companies, research institutes, and alternative treatment modalities. For instance, On May 2021, Basilea Pharmaceutical Ltd. (SIX: BSLN) announced today that it has been awarded a grant of up to USD 2.7 million from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), a global partnership dedicated to supporting the early development of antibacterial products to diagnose, prevent and treat drug-resistant infections.
Recent Developments:
November 18, 2020, Merck, known as MSD outside the United States and Canada, recently, announced the launch of a new website for the global Study for Monitoring Antimicrobial Resistance Trends (SMART). SMART, which was initiated in 2002, is one of the world's largest and longest-running antimicrobial resistance (AMR) surveillance studies including more than 200 sites across more than 60 countries.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTIBIOTIC RESISTANCE MARKET KEY PLAYERS
- Achaogen Inc
- Nabriva Therapeutics plc
- BioVersys AG
- Johnson & Johnson Services, Inc.
- Destiny Pharma plc
- Armata Pharmaceuticals, Inc.
- West Way Health
- The Medicines Company
- Merck & Co., Inc.
- Pfizer Inc.
- CARB-X
- Melinta Therapeutics LLC
- Novartis AG
- Vertex Pharmaceuticals Incorporated
- GSK plc.
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY DISEASE TYPE
- Urinary Tract Infection
- Intra-Abdominal Infections
- Blood Stream Infections
- Clostridium Difficile Infections
- Others
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY PATHOGEN TYPE
- Acinetobacter Baumannii
- Pseudomonas Aeruginosa
- Staphylococcus Aureus
- Streptococcus pneumoniae
- Others
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY DRUG CLASS
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Others
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY END-USER
- Hospitals
- Homecare
- Specialty Clinics
- Others
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1722
Table of Contents
1. Antibiotic Resistance Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Antibiotic Resistance Market Snippet by Disease Type
- 2.1.2. Antibiotic Resistance Market Snippet by Pathogen Type
- 2.1.3. Antibiotic Resistance Market Snippet by Drug Class
- 2.1.4. Antibiotic Resistance Market Snippet by End-User
- 2.1.5. Antibiotic Resistance Market Snippet by Country
- 2.1.6. Antibiotic Resistance Market Snippet by Region
- 2.2. Competitive Insights
3. Antibiotic Resistance Key Market Trends
- 3.1. Antibiotic Resistance Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Antibiotic Resistance Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Antibiotic Resistance Market Opportunities
- 3.4. Antibiotic Resistance Market Future Trends
4. Antibiotic Resistance Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Antibiotic Resistance Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Antibiotic Resistance Market Landscape
- 6.1. Antibiotic Resistance Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Antibiotic Resistance Market - By Disease Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
- 7.1.2. Urinary Tract Infection
- 7.1.3. Intra-Abdominal Infections
- 7.1.4. Blood Stream Infections
- 7.1.5. Clostridium Difficile Infections
- 7.1.6. Others
8. Antibiotic Resistance Market - By Pathogen Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Pathogen Type, 2022 & 2030 (%)
- 8.1.2. Acinetobacter Baumannii
- 8.1.3. Pseudomonas Aeruginosa
- 8.1.4. Staphylococcus Aureus
- 8.1.5. Streptococcus pneumoniae
- 8.1.6. Others
9. Antibiotic Resistance Market - By Drug Class
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
- 9.1.2. Oxazolidinones
- 9.1.3. Lipoglycopeptides
- 9.1.4. Tetracyclines
- 9.1.5. Others
10. Antibiotic Resistance Market - By End-User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
- 10.1.2. Hospitals
- 10.1.3. Homecare
- 10.1.4. Specialty Clinics
- 10.1.5. Others
11. Antibiotic Resistance Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Antibiotic Resistance Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Antibiotic Resistance Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.9. Italy
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.9.3. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.9.4. Italy Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.9.5. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.9.6. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.10. United Kingdom
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.10.3. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.10.4. United Kingdom Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.10.5. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.11. France
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.11.3. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.11.4. France Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.11.5. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.11.6. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.12. Russia
- 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.12.2. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.12.3. Russia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.12.4. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.12.5. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.13. Netherlands
- 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.13.2. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.13.3. Netherlands Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.13.4. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.14.2. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.15. Poland
- 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.15.2. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.15.3. Poland Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.15.4. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.15.5. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.3.16. Rest of Europe
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.3.16.4. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.3.16.5. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Antibiotic Resistance Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.8. India
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.8.3. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.8.4. India Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.8.5. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.8.6. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.9.3. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.9.4. China Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.9.5. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.9.6. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.13. Thailand
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.13.4. Thailand Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.13.5. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.14. Indonesia
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.14.3. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.14.4. Indonesia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.14.5. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Antibiotic Resistance Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Antibiotic Resistance Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Antibiotic Resistance Industry
- 12.1. Competitive Dashboard
- 12.2. Company Profiles
- 12.2.1. Achaogen Inc
- 12.2.2. Nabriva Therapeutics plc
- 12.2.3. BioVersys AG
- 12.2.4. Johnson & Johnson Services, Inc.
- 12.2.5. Destiny Pharma plc
- 12.2.6. Armata Pharmaceuticals, Inc.
- 12.2.7. West Way Health
- 12.2.8. The Medicines Company
- 12.2.9. Merck & Co., Inc.
- 12.2.10. Pfizer Inc.
- 12.2.11. CARB-X
- 12.2.12. Melinta Therapeutics LLC
- 12.2.13. Novartis AG
- 12.2.14. Vertex Pharmaceuticals Incorporated
- 12.2.15. GSK plc.
- 12.2.16. AbbVie Inc.
- 12.2.17. F. Hoffmann-La Roche Ltd
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
Product Code: ANV1722
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Antibiotic Resistance Market: Disease Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Disease Type
- TABLE Global Antibiotic Resistance Market, by Disease Type 2018-2030 (USD Million)
- TABLE Antibiotic Resistance Market: Pathogen Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Pathogen Type
- TABLE Global Antibiotic Resistance Market, by Pathogen Type 2018-2030 (USD Million)
- TABLE Antibiotic Resistance Market: Drug Class Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Drug Class
- TABLE Global Antibiotic Resistance Market, by Drug Class 2018-2030 (USD Million)
- TABLE Antibiotic Resistance Market: End-User Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End-User
- TABLE Global Antibiotic Resistance Market, by End-User 2018-2030 (USD Million)
- TABLE Antibiotic Resistance Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Antibiotic Resistance Market, by Region 2018-2030 (USD Million)
- TABLE North America Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
- TABLE North America Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
- TABLE North America Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
- TABLE North America Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
- TABLE North America Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)
- TABLE Europe Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
- TABLE Europe Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
- TABLE Europe Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
- TABLE Europe Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)
- TABLE Asia Pacific Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
- TABLE Asia Pacific Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)
- TABLE Latin America Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
- TABLE Latin America Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
- TABLE Latin America Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
- TABLE Latin America Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)
- TABLE Middle East and Africa Antibiotic Resistance Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Antibiotic Resistance Market, by Disease Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Antibiotic Resistance Market, by Pathogen Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Antibiotic Resistance Market, by Drug Class, 2018-2030 (USD Million)
- TABLE Middle East and Africa Antibiotic Resistance Market, by End-User, 2018-2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.